Berlin - Delayed Quote EUR
Nicox SA (NXOA.BE)
0.2275
+0.0015
+(0.66%)
As of 3:44:03 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-23,125
-18,481
-5,392
Investing Cash Flow
--
132
-175
4,949
Financing Cash Flow
--
8,643
13,409
19,584
End Cash Position
--
27,650
41,970
47,195
Capital Expenditure
--
-42
-8
-20
Issuance of Capital Stock
--
218
91
--
Issuance of Debt
--
8,964
13,713
20,597
Repayment of Debt
--
-165
--
--
Repurchase of Capital Stock
--
--
--
-633
Free Cash Flow
--
-23,167
-18,489
-5,412
12/31/2020 - 9/18/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
0M4.DU Mersana Therapeutics Inc
0.3383
+0.06%
GON.DU Geron Corp
1.2350
+0.90%
300759.SZ Pharmaron Beijing Co., Ltd.
23.08
+1.58%
OCD1.MU ChromaDex Corp
6.20
+3.33%
PI3.DU Gubra AS
46.80
-2.94%
50BA.F Bicycle Therapeutics plc
6.75
-11.18%